Decoding glioblastoma recurrence: harnessing radiomics and machine learning for early prediction
5 affiliations
- 1Department of Medical Imaging, The Second Hospital of Hebei Medical University
- 2Department of Clinical Radiology, Kuopio University Hospital
- 3Department of Neurology, University of Eastern Finland
- 4Department of Ultrasound, The Second Hospital of Hebei Medical University
- 5Department of Experimental Center, College of Hebei Medical University
Abstract
Objective: This study aimed to analyze postoperative periresidual FLAIR hyperintensity and assess radiomic features from periresidual enhancing and non-enhancing subregions for predicting early GBM recurrence (pre-CRT RANO criteria). We also evaluated the incremental prognostic value of multi-subregion radiomic signatures over conventional clinical and MRI features.
Methods: Adult patients with surgically confirmed GBM were retrospectively enrolled and randomly split into training ( n = 128) and test ( n = 56) cohorts at a 7:3 ratio. Postoperative pre-radiotherapy CE-T1WI and FLAIR images were fused to semi-automatically delineate periresidual enhancing (ROI-1) and non-enhancing hyperintense (ROI-2) regions using 3D Slicer. Radiomic features were extracted from both subregions and their fusion area. LASSO regression was used to select optimal features related to early recurrence from ROI-1, ROI-2, and combined subregion datasets. Five machine learning algorithms (DT, LR, NB, SVM, XGBoost) were applied to build radiomic prediction models. To evaluate the incremental value of radiomic signatures, a clinical/MRI-only baseline model was constructed using conventional clinical and morphological MRI features. Multivariate logistic regression was performed to identify independent clinical and MRI predictors. A quantitative Rad-score was generated based on the optimal combined radiomic features, and an integrated radiomics-clinical model with a predictive nomogram was established by incorporating the Rad-score and independent clinical/MRI variables. Ten-fold cross-validation was used for internal validation. Model performance was comprehensively assessed using ROC curves, calibration curves, and decision curve analysis in terms of discrimination, calibration, and clinical utility.
Results: A logistic regression analysis of 184 GBM cases found subventricular zone involvement [HR 4.868 (1.657–14.308), p = 0.004] and partial resection [HR 3.640 (1.341–9.883), p = 0.011] as predictors of early recurrence. The baseline model achieved an AUC of 0.701. Among five models using ROI-1 features, XGBoost performed best with validation AUC of 0.663. For ROI-2, the DT model excelled with 0.713. Combining ROI-1 and ROI-2, XGBoost achieved 0.752. Integrating radiomics with clinical and MRI data, XGBoost reached 0.817. DCA indicated the combined model had the highest clinical effectiveness. DCA showed that a threshold probability of 0.1 to 0.6 yields a net gain.
Conclusion: In-depth analysis of the enhanced and non-enhanced regions, within the FLAIR hyperintense surrounding the residual cavity of GBM before pre-CRT using ML, has revealed certain value for the early prediction of GBM recurrence. Furthermore, a combined model incorporating radiomic features, clinical and conventional MRI attributes enhances the predictive accuracy for survival prognosis.
Related
- Pixel-Wise Prediction of Glioblastoma Recurrence Using Mid-Treatment MRI and Deep Learning
- Response to “radiomics of mandibular osteoradionecrosis with recurrence: The need for etiologic and temporal validation”
- Radiomics of mandibular osteoradionecrosis with recurrence: the need for etiologic and temporal validation
- Neoplastic and non-neoplastic astrocyte states converge on mesenchymal and injury-response programs during glioblastoma recurrence
- Explainable DSC Perfusion Radiomics for Post-Treatment Glioblastoma Assessment Using a Soft-Voting Machine-Learning Ensemble
BibTeX
@article{gao2026decoding,
title = {{Decoding glioblastoma recurrence: harnessing radiomics and machine learning for early prediction}},
author = {Lijuan Gao and Tao Yuan and Yawu Liu and Xiao Liu and Bocong Gao and Xiaoyun Yang and Yiming Li and Guanmin Quan},
journal = {Frontiers in Neurology},
year = {2026},
month = nov,
doi = {10.3389/fneur.2026.1909375},
url = {https://www.frontiersin.org/articles/10.3389/fneur.2026.1909375/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Decoding glioblastoma recurrence: harnessing radiomics and machine learning for early prediction
AU - Lijuan Gao
AU - Tao Yuan
AU - Yawu Liu
AU - Xiao Liu
AU - Bocong Gao
AU - Xiaoyun Yang
AU - Yiming Li
AU - Guanmin Quan
PY - 2026
DA - 2026/11/02
JO - Frontiers in Neurology
DO - 10.3389/fneur.2026.1909375
UR - https://www.frontiersin.org/articles/10.3389/fneur.2026.1909375/full
AB - Objective: This study aimed to analyze postoperative periresidual FLAIR hyperintensity and assess radiomic features from periresidual enhancing and non-enhancing subregions for predicting early GBM recurrence (pre-CRT RANO criteria). We also evaluated the incremental prognostic value of multi-subregion radiomic signatures over conventional clinical and MRI features. Methods: Adult patients with surgically confirmed GBM were retrospectively enrolled and randomly split into training ( n = 128) and test ( n = 56) cohorts at a 7:3 ratio. Postoperative pre-radiotherapy CE-T1WI and FLAIR images were fused to semi-automatically delineate periresidual enhancing (ROI-1) and non-enhancing hyperintense (ROI-2) regions using 3D Slicer. Radiomic features were extracted from both subregions and their fusion area. LASSO regression was used to select optimal features related to early recurrence from ROI-1, ROI-2, and combined subregion datasets. Five machine learning algorithms (DT, LR, NB, SVM, XGBoost) were applied to build radiomic prediction models. To evaluate the incremental value of radiomic signatures, a clinical/MRI-only baseline model was constructed using conventional clinical and morphological MRI features. Multivariate logistic regression was performed to identify independent clinical and MRI predictors. A quantitative Rad-score was generated based on the optimal combined radiomic features, and an integrated radiomics-clinical model with a predictive nomogram was established by incorporating the Rad-score and independent clinical/MRI variables. Ten-fold cross-validation was used for internal validation. Model performance was comprehensively assessed using ROC curves, calibration curves, and decision curve analysis in terms of discrimination, calibration, and clinical utility. Results: A logistic regression analysis of 184 GBM cases found subventricular zone involvement [HR 4.868 (1.657–14.308), p = 0.004] and partial resection [HR 3.640 (1.341–9.883), p = 0.011] as predictors of early recurrence. The baseline model achieved an AUC of 0.701. Among five models using ROI-1 features, XGBoost performed best with validation AUC of 0.663. For ROI-2, the DT model excelled with 0.713. Combining ROI-1 and ROI-2, XGBoost achieved 0.752. Integrating radiomics with clinical and MRI data, XGBoost reached 0.817. DCA indicated the combined model had the highest clinical effectiveness. DCA showed that a threshold probability of 0.1 to 0.6 yields a net gain. Conclusion: In-depth analysis of the enhanced and non-enhanced regions, within the FLAIR hyperintense surrounding the residual cavity of GBM before pre-CRT using ML, has revealed certain value for the early prediction of GBM recurrence. Furthermore, a combined model incorporating radiomic features, clinical and conventional MRI attributes enhances the predictive accuracy for survival prognosis.
SN - 1664-2295
ER -